Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...

At its core, conservation is about behavior change. Yet few organizations have put in place the structure, standards, and ...

Tea may offer powerful health benefits, but how it is prepared and consumed matters. Tea has a long history as both a ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...

HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar grant to researchers to carry out an unethical and scientifically unjustified randomized clinical trial of the birth dose o ...

This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...

Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...

On November 8, 2025, the Faculty of Education at East China Normal University hosted a grand ceremony to present the second ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...